Revolutionizing the future of immune-based
treatment.
Accelerating Preclinical Research and Development of Antibody and Chimeric Antigen Receptor (CAR) Therapies.
We provide end-to-end preclinical Research and Development Organization (CRDO) services to accelerate Antibody and Cellular Immunotherapy (CAR-T/NK).
Robust analytical capabilities to guarantee the safety, quality, and effectiveness of cell and gene therapy products.
Customized guidance and strategic support for biotech companies and academic researchers driving therapeutic breakthroughs.
© 2025 ImmuniteBio - All Rights Reserved